Neuralink: US FDA cited animal lab at Musk's Neuralink for 'objectionable conditions'

FDA inspectors identified the issues at Neuralink's animal testing facilities in California in June 2023, several weeks after the agency had given the company the green light for a small study of its brain implant in humans, according to the letter to Congress dated November 29.